INDOCO REMEDIES
Back to Balance Sheet
|
INDOCO REMEDIES Last 5 Year Long Term Provisions History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Long Term Provisions | ₹36 Cr | ₹34 Cr | ₹33 Cr | ₹32 Cr | ₹66 Cr |
What is the latest Long Term Provisions ratio of INDOCO REMEDIES ?
| Year | Long Term Provisions |
|---|---|
| Mar2025 | ₹36 Cr |
| Mar2024 | ₹34 Cr |
| Mar2023 | ₹33 Cr |
| Mar2022 | ₹32 Cr |
| Mar2021 | ₹66 Cr |
How is Long Term Provisions of INDOCO REMEDIES Trending?
| Years | Long Term Provisions | % Change | |
|---|---|---|---|
| Mar2025 | ₹36 Cr | 6.35 | |
| Mar2024 | ₹34 Cr | 0.86 | |
| Mar2023 | ₹33 Cr | 5.20 | |
| Mar2022 | ₹32 Cr | -52.15 | |
| Mar2021 | ₹66 Cr | - | |
Compare Long Term Provisions of peers of INDOCO REMEDIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| INDOCO REMEDIES | ₹1,908.1 Cr | -2.1% | -14% | -36.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹386,905.0 Cr | -5.2% | -7.6% | -8.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹159,357.0 Cr | -5.6% | -7.3% | 1.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹134,788.0 Cr | -0.6% | 4.8% | 25% | Stock Analytics | |
| CIPLA | ₹110,628.0 Cr | -4.5% | -9.7% | -4.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹96,441.5 Cr | -2.6% | -9.7% | -10.5% | Stock Analytics | |
INDOCO REMEDIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| INDOCO REMEDIES | -2.1% |
-14% |
-36.1% |
| SENSEX | -2.1% |
-3% |
6.8% |
You may also like the below Video Courses